| Product NDC: | 24208-416 |
| Proprietary Name: | Retisert |
| Non Proprietary Name: | Fluocinolone Acetonide |
| Active Ingredient(s): | .59 mg/1 & nbsp; Fluocinolone Acetonide |
| Administration Route(s): | INTRAVITREAL |
| Dosage Form(s): | IMPLANT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 24208-416 |
| Labeler Name: | Bausch & Lomb Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021737 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050408 |
| Package NDC: | 24208-416-01 |
| Package Description: | 1 POUCH in 1 CARTON (24208-416-01) > 1 IMPLANT in 1 POUCH |
| NDC Code | 24208-416-01 |
| Proprietary Name | Retisert |
| Package Description | 1 POUCH in 1 CARTON (24208-416-01) > 1 IMPLANT in 1 POUCH |
| Product NDC | 24208-416 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fluocinolone Acetonide |
| Dosage Form Name | IMPLANT |
| Route Name | INTRAVITREAL |
| Start Marketing Date | 20050408 |
| Marketing Category Name | NDA |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | FLUOCINOLONE ACETONIDE |
| Strength Number | .59 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |